Nestlé reports half-year results for 2024

In This Article:

Nestlé S.A.
Nestlé S.A.

[Ad hoc announcement pursuant to Art. 53 LR]

This press release is also available in Français (pdf) and Deutsch (pdf)

Follow today's event live
14:00 CEST Investor Q&A audio webcast
Full details on our website

Report published today
Half-Year Report (pdf)

Other language versions available in Publications

.............


Vevey, July 25, 2024

Nestlé reports half-year results for 2024



  • Organic growth of 2.1%, with positive real internal growth (RIG) of 0.1% for the first half and 2.2% for the second quarter improving in all Zones and categories. Pricing of 2.0%.

  • Total reported sales of CHF 45.0 billion (-2.7%), with an impact from foreign exchange of -4.4% and net divestitures of -0.4%.

  • Underlying trading operating profit (UTOP) margin increased 30 basis points to 17.4% on a reported basis and up 40 basis points in constant currency.

  • Trading operating profit (TOP) margin increased 50 basis points to 16.4% on a reported basis.

  • Underlying earnings per share up 3.3% in constant currency (-1.0% on a reported basis to CHF 2.40). Earnings per share increased 1.8% to CHF 2.16 on a reported basis.

  • Free cash flow up CHF 0.6 billion to CHF 4.0 billion.

  • Full-year 2024 outlook updated: we expect organic sales growth of at least 3%. Underlying earnings per share in constant currency is expected to increase at a mid single-digit rate. Underlying trading operating profit margin guidance unchanged with a moderate increase expected.

Mark Schneider, Nestlé CEO, commented: “Positive real internal growth is back. We delivered improved volume and mix growth across the Group in the second quarter. Nestlé Health Science is recovering as planned and is set for a strong second half. Looking ahead to the remainder of the year, we will continue to drive RIG by launching innovations that address consumer trends and growing our large iconic brands. At the same time, we have seen pricing come down faster than expected. Therefore, we consider it prudent to adjust our guidance for the year, with organic sales growth now expected to be at least 3%.”

 

Total Group

Zone North America

Zone Europe

Zone AOA

Zone Latin America

Zone Greater China

Nestlé Health Science

Nespresso

Other Businesses

Sales 6M-2024 (CHF m)

45 045

12 234

9 283

8 441

6 166

2 440

3 239

3 096

146

Sales 6M-2023 (CHF m)

46 293

12 553

9 467

9 060

6 082

2 548

3 318

3 128

137

Real internal growth (RIG)

0.1%

- 1.5%

1.3%

0.0%

0.1%

2.9%

- 0.2%

1.1%

8.4%

Pricing

2.0%

1.4%

3.1%

3.5%

2.5%

- 1.3%

0.4%

0.7%

1.4%

Organic growth

2.1%

- 0.1%

4.5%

3.5%

2.7%

1.6%

0.1%

1.8%

9.7%

Net M&A

- 0.4%

0.0%

- 2.7%

0.0%

- 0.1%

0.2%

0.4%

0.1%

0.0%

Foreign exchange

- 4.4%

- 2.5%

- 3.7%

- 10.3%

- 1.1%

- 6.1%

- 3.0%

- 2.9%

- 3.9%

Reported sales growth

- 2.7%

- 2.5%

- 1.9%

- 6.8%

1.4%

- 4.2%

- 2.4%

- 1.0%

6.0%

6M-2024 Underlying TOP Margin

17.4%

21.8%

17.7%

23.8%

19.8%

15.8%

13.4%

21.5%

- 2.9%

6M-2023 Underlying TOP Margin

17.1%

21.6%

16.6%

22.8%

19.8%

16.6%

13.0%

21.7%

- 12.5%